ERRANT GENE THERAPEUTICS LLC has a total of 22 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GRINDEKS JOINT STOCK COMPANY, LABORATORIO CHIMICO INT S P A and SEQUELLA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lan-Hargest Hsuan-Yin | 22 |
#2 | Kaufman Robert J | 17 |
#3 | Wiech Norbert L | 12 |
Publication | Filing date | Title |
---|---|---|
US2010234455A1 | Histone Deacetylase Inhibitors | |
US2007037869A1 | Histone deacetylase inhibitors | |
AU2003291097A1 | Treatment of lung cells with histone deacetylase inhibitors | |
CA2783647A1 | Histone deacetylase inhibitors | |
US2002143037A1 | Histone deacetylase inhibitors | |
US7312247B2 | Histone deacetylase inhibitors |